www.gsk.com

• charset: utf-8
• name: viewport content: width=device-width, initial-scale=1
• name: site-section content: Home
• name: description content: At GSK, we unite science, technology and talent to get ahead of disease together
• property: og:description content: At GSK, we unite science, technology and talent to get ahead of disease together
• property: og:image:width content: 400
• property: og:image:height content: 300
• property: og:title content: Home | GSK
• property: og:description content: At GSK, we unite science, technology and talent to get ahead of disease together
• property: og:image content: https://www.gsk.com/media/p3clrlre/stvg_2_2022_smtlab_17_hess.jpg?width=600&format=webp&quality=100&v=1dbd496701ca530
• property: og:url content: https://www.gsk.com/en-gb/home/
• name: twitter:description content: At GSK, we unite science, technology and talent to get ahead of disease together
• name: twitter:card content: summary_large_image
• name: twitter:site content: @gsk
• name: twitter:title content: Home | GSK
• name: twitter:description content: At GSK, we unite science, technology and talent to get ahead of disease together
• name: twitter:image content: https://www.gsk.com/media/p3clrlre/stvg_2_2022_smtlab_17_hess.jpg?width=600&format=webp&quality=100&v=1dbd496701ca530
• name: twitter:url content: https://www.gsk.com/en-gb/home

• Skip to content
• Skip to search
• http://www.gsk.com/
• Behind the Science magazine
• Company
• Close video
• Purpose, strategy and culture
• Outstanding people
• Great place to work
• Meet our veterans
• Working together
• My GSK story
• Innovating together
• GSK at a glance
• History and heritage
• Board of Directors and Executive Committee
• Board information
• Governance
• Committees
• Shareholders
• Sarbanes-Oxley Act 2002
• Compliance
• Policy positions
• Codes, standards and reports
• Innovation
• Our leading scientists
• Dr Tony Wood
• Dr Sabine Luik
• Dr Hesham Ahmed Abdullah
• Dr Kaivan Khavandi
• Research and development approach
• Pipeline
• Therapeutic areas
• Go to respiratory, immunology and inflammation
• Go to oncology
• Go to HIV
• Go to infectious diseases
• Tech
• Clinical trials at GSK
• Provision of unapproved medicines for unmet medical needs
• Data transparency
• Representative clinical studies
• Partnerships
• Supported studies
• R&D locations
• Products
• Product areas
• Products A-Z
• Responsibility
• Access
• Global health and health security
• Global health
• Health security
• Using our science for global health
• Improving access to healthcare
• Africa Open Lab
• Environment
• Climate
• Freshwater
• Land
• Oceans
• Atmosphere
• Materials and waste
• Health system sustainability
• Inclusion
• Ethical standards
• Working with third parties
• Public policy and patient advocacy
• Human rights
• Use of animals
• Engaging with healthcare professionals
• Product governance
• Grants and donations
• Charitable investments
• Responsibility reports
• Reports archive
• Investors
• Why invest in GSK?
• View latest results
• Financial reports
• Annual Report 2024
• Corporate reports archive
• Responsible business
• Speeches and presentations
• Science publications
• Events calendar
• Dividend and share price
• GSK share price
• Go to calculator
• Dividend calculators (GBp/USD)
• Dividend calendar
• Analyst consensus
• Stock exchange announcements
• London (RNS)
• London (RNS) inside information
• New York (SEC)
• Sign up for announcements
• Shareholder information
• Manage your shares
• Annual General Meeting
• General Meeting
• Annual Governance Meeting
• Corporate sponsored nominee service
• Our ADR programme
• Asset reunification - Georgeson
• Share scam alert
• Privacy notice for ordinary shareholders
• FAQs
• Corporate actions
• Consumer Healthcare Demerger
• Consumer Healthcare Joint Venture
• Agreement to acquire TESARO
• Debt investors
• Investor contacts
• Media
• Press releases
• Media contacts
• Media library
• Zantac litigation
• Social media directory
• Podcasts
• http://www.gsk.com/en-gb/media/rss-feeds/
• Careers
• Search jobs
• Featured careers
• A career in data
• Life at GSK
• Experienced professionals
• Business operations
• Engineering at GSK
• Global supply chain
• Sales and marketing
• Research and development
• Chemical Manufacturing and Controls (CMC), Medicine Development and Supply (MDS)
• Genomic sciences
• Technology
• Early careers
• Application process
• Apprentice programmes
• Internships and placements
• Graduate programme
• Business operations
• Engineering
• Manufacturing & supply
• Commercial
• Research & development
• Digital & tech
• Manufacturing sciences & technology
• Post graduate opportunities
• Frequently asked questions
• Veterans
• Our global and regional hubs
• How we hire
• Fraudulent internet recruitment activities
• Frequently asked questions
• More info
• Contact us
• http://www.gsk.com/en-gb/
• Locations selector
• http://www.gsk.com/en-gb/behind-the-science-magazine/organoids-digital-twin-comment/
• http://www.gsk.com/en-gb/behind-the-science-magazine/nasal-polyps-asthma-patient-comment/
• http://www.gsk.com/en-gb/behind-the-science-magazine/long-acting-therapies-hiv-comment/
• http://www.gsk.com/en-gb/behind-the-science-magazine/cancer-chronic-manageable-disease-comment/
• http://www.gsk.com/en-gb/behind-the-science-magazine/prevention-medicine-hiv-epidemic/
• http://www.gsk.com/en-gb/behind-the-science-magazine/blood-cancer-myeloma-myelofibrosis-feature/
• Previous slide
• Next slide
• > Modern Slavery Act Statement 2024
• Report a possible side effect
• GSK Speak up
• Accessibility
• Digital sustainability
• Terms of use
• Cookie policy
• Sitemap
• Cookie Policy

• GSKPro for healthcare professionals
• GSK study register
• Supplier website
• ViiV Healthcare
• http://www.linkedin.com/company/glaxosmithkline
• http://twitter.com/GSK
• https://bsky.app/profile/gsk.bsky.social/
• https://www.instagram.com/gsk/
• https://www.facebook.com/GSK
• http://www.youtube.com/GSK
• Privacy notice

            Domain Name: GSK.COM
Registrar: SafeNames Ltd.
Domain Status: client delete prohibited
Domain Status: client transfer prohibited
Domain Status: server delete prohibited
Domain Status: server transfer prohibited
Domain Status: server update prohibited
Creation Date: 1998-08-07T04:00:00Z
Registry Expiry Date: 2026-08-06T04:00:00Z
Updated Date: 2025-08-06T23:52:01Z
Name Server: C1-160.AKASHIELD.NET
Name Server: C2-160.AKASHIELD.NET
REGISTRAR Contact: SafeNames Ltd.
>>> Last update of RDAP database: 2026-02-25T17:00:04Z         

			User-agent: *
Allow: /
Disallow: /search
Sitemap: https://www.gsk.com/sitemap.xml        

Техническое SEO

SEO на странице

Контент и UX